| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| BioXcel Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 17,000 | 09 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| BTAI | BioXcel Therapeutics, Inc. | 09 Jan 2026 | 1 | $0 | 4 | Director | 12 Jan 2026, 19:06 |
| BTAI | BioXcel Therapeutics, Inc. | 10 Jun 2024 | 1 | $0 | 4 | Director | 11 Jun 2024, 19:01 |
| BTAI | BioXcel Therapeutics, Inc. | 26 Jun 2023 | 1 | $0 | 4 | Director | 28 Jun 2023, 17:01 |
| BTAI | BioXcel Therapeutics, Inc. | 19 May 2022 | 1 | $0 | 4 | Director | 23 May 2022, 18:49 |
| BTAI | BioXcel Therapeutics, Inc. | 11 Jun 2021 | 1 | $0 | 4 | Director | 15 Jun 2021, 17:33 |